Community lists
Curadoria · Saúde

Big pharma

Por InspectStocksPublished 14 de out. de 202613 companies0 follower

The largest drugmakers, selling prescription medicines worldwide.

Agrupadas com a ajuda de um modelo de IA e revisadas pelos nossos editores. A linha abaixo de cada empresa diz por que ela está aqui.

A
  • LLYELI Lilly
    US$ 1.437,79+42,2% 1Y

    Sells prescription medicines for diabetes, obesity, cancer and inflammation

  • JNJJohnson & Johnson
    US$ 280,34+47,5% 1Y

    Sells prescription medicines for cancer and immune disorders

  • MRKMerck
    US$ 147,20+65,7% 1Y

    Sells prescription medicines and vaccines for people and animals

  • NVSNovartis
    US$ 160,36+23,6% 1Y

    Sells prescription medicines

  • AMGNAmgen
    US$ 468,13+43,1% 1Y

    Develops and sells medicines and biosimilars for serious diseases

  • GSKGSK
    US$ 50,60+8,9% 1Y

    Sells prescription medicines and vaccines worldwide

  • TAKTakeda Pharmaceutical
    US$ 20,86+50,1% 1Y

    Sells prescription medicines and vaccines globally

B
  • ABBVAbbVie
    US$ 294,87+30,2% 1Y

    Sells medicines for immune, neurological and cancer conditions

  • AZNUm degrau abaixo porque o crescimento está perdendo forçaAstrazeneca
    US$ 185,49+115,2% 1Y

    Sells prescription medicines

  • SNYSanofi
    US$ 48,43-3,0% 1Y

    Sells prescription medicines and vaccines

C
  • NVONovo Nordisk A/S
    US$ 41,10-15,4% 1Y

    Sells diabetes and obesity medicines

  • PFEUm degrau abaixo porque o crescimento está perdendo forçaPfizer
    US$ 29,45+21,4% 1Y

    Sells prescription medicines and vaccines

  • BMYBristol-Myers Squibb
    US$ 62,92+34,0% 1Y

    Sells prescription medicines for cancer and immune conditions

D

Nenhuma empresa aqui tem esta nota.

F

Nenhuma empresa aqui tem esta nota.

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.